167 related articles for article (PubMed ID: 38420767)
21. Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?
Razavi AC; Jain V; Grandhi GR; Patel P; Karagiannis A; Patel N; Dhindsa DS; Liu C; Desai SR; Almuwaqqat Z; Sun YV; Vaccarino V; Quyyumi AA; Sperling LS; Mehta A
J Clin Endocrinol Metab; 2024 Jan; 109(2):321-332. PubMed ID: 37437107
[TBL] [Abstract][Full Text] [Related]
22. High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the "U"-Shaped Curve.
Razavi AC; Mehta A; Jain V; Patel P; Liu C; Patel N; Eisenberg S; Vaccarino V; Isiadinso I; Sperling LS; Quyyumi AA
Curr Cardiol Rep; 2023 Dec; 25(12):1725-1733. PubMed ID: 37971636
[TBL] [Abstract][Full Text] [Related]
23. Influences of resolvin D1 and D2 on the risk of type 2 diabetes mellitus: a Chinese community-based cohort study.
Sun Q; Wang J; Jing Y; Liu J; Jin J; Wang S; Zhang J; Liu K; Chen X; Zhou H; Dong C
Front Immunol; 2023; 14():1143456. PubMed ID: 37334388
[TBL] [Abstract][Full Text] [Related]
24. The association between essential trace element mixture and atherosclerotic cardiovascular disease risk among Chinese community-dwelling older adults.
Meng XL; Wang Y; Wang HL; Nie HH; Cheng BJ; Cao HJ; Li XD; Wang SF; Chen GM; Tao FB; Sheng J; Yang LS
Environ Sci Pollut Res Int; 2022 Dec; 29(60):90351-90363. PubMed ID: 35869340
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the
Yu C; Bakshi A; Watts GF; Renton AE; Fulton-Howard B; Goate AM; Natarajan P; Chasman DI; Robman L; Woods RL; Guymer R; Wolfe R; Thao LTP; McNeil JJ; Tonkin AM; Nicholls SJ; Lacaze P
J Am Heart Assoc; 2023 Nov; 12(21):e031459. PubMed ID: 37929782
[TBL] [Abstract][Full Text] [Related]
26. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
[TBL] [Abstract][Full Text] [Related]
27. Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China.
Zhang X; Liu J; Wang M; Qi Y; Sun J; Liu J; Wang Y; Hao Y; Li Y; Zhou M; Zhao D
J Clin Lipidol; 2018; 12(5):1179-1189.e4. PubMed ID: 30037589
[TBL] [Abstract][Full Text] [Related]
28. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H; Zhang M; Liu J; Wang J; Ren G
Curr Atheroscler Rep; 2023 Apr; 25(4):155-166. PubMed ID: 36881278
[TBL] [Abstract][Full Text] [Related]
29. Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease.
Lin Z; Chen Y; Xiao Z; Xu W; Chen G; Huang C; Feng W; Xie Z; Liao W; Liao Y; Bin J; Feng L; Wang S
Mayo Clin Proc; 2023 Sep; 98(9):1280-1296. PubMed ID: 37661139
[TBL] [Abstract][Full Text] [Related]
30. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
[TBL] [Abstract][Full Text] [Related]
31. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
[TBL] [Abstract][Full Text] [Related]
32. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study.
Wang M; Wang Z; Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):e273-e288. PubMed ID: 35912635
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
34. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.
Zheng J; Hu Y; Xu H; Lei Y; Zhang J; Zheng Q; Li L; Tu W; Chen R; Guo Q; Zang X; You Q; Xu Z; Zhou Q; Wu X
Cardiovasc Diabetol; 2023 Jun; 22(1):137. PubMed ID: 37308932
[TBL] [Abstract][Full Text] [Related]
35. Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.
Cao J; Remaley AT; Guan W; Devaraj S; Tsai MY
Atherosclerosis; 2021 Jun; 327():1-4. PubMed ID: 34004482
[TBL] [Abstract][Full Text] [Related]
36. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
37. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
Delialis D; Georgiopoulos G; Aivalioti E; Mavraganis G; Dimopoulou AM; Sianis A; Aggelidakis L; Patras R; Petropoulos I; Ioannou S; Syrigou R; Chatzidou S; Kanakakis I; Stellos K; Stamatelopoulos K
Hellenic J Cardiol; 2022; 66():26-31. PubMed ID: 35667617
[TBL] [Abstract][Full Text] [Related]
38. Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study.
Guan XM; Shi HP; Xu S; Chen Y; Zhang RF; Dong YX; Gao LJ; Wu SL; Xia YL
Front Cardiovasc Med; 2023; 10():1105342. PubMed ID: 37273877
[TBL] [Abstract][Full Text] [Related]
39. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
40. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
